Medinexo

What Medinexo does

Medinexo is a US-headquartered (Wyoming LLC, St. Louis, Missouri) healthcare communications network operating a multi-sided platform that connects clinical trial sponsors, biotech investors, and healthcare providers. The company serves three core constituencies: (1) biotech and pharma sponsors seeking rapid access to pre-qualified investigative sites, (2) healthcare providers and research sites that monetize participation through site recruitment and data licensing, and (3) individual doctors and patients using telemedicine tools. Its product stack is organized around three flagship brands — ResearchNexo© (site recruitment, credentialing, and federated real-world data marketplace), TeamNexo© (clinical team management and HIPAA-compliant communications), and PatientNexo© (telemedicine with WhatsApp/SMS patient interface) — supplemented by subscription products including Sponsor Prime ($485/month), Site Prime ($99/month with a free tier), Biotech Investor Services, and CRAACO (Clinical Research as a Care Option) for patient trial access.

The underlying technology architecture combines a digital site qualification and credential management platform (including the GDPR Wallet electronic credential system) with a federated computing layer, enabled through a strategic partnership with Rhino Health, that allows institutions to monetize clinical data without patient data leaving their servers. Federated computing is SOC 2 Type 2 and ISO 27001 certified, with HIPAA Business Associate Agreements and FDA Part 11 / ICH GCP compliance referenced. Medinexo claims a network of 1,800+ pre-qualified research sites across 35+ countries, with stated clientele concentration in underrepresented communities and active presence in the United States, Latin America, and India.

The business model is a hybrid of subscription and marketplace monetization. Revenue streams include sponsor subscriptions (Sponsor Prime at $485/month with $2,501 per-site recruiting fees and a 90-day money-back guarantee), site subscriptions (Prime Site at $99/month), a 10% transaction fee on PatientNexo doctor services, and marketplace commissions through the ResearchNexo Interface Processor (RNX IP) data marketplace where institutions set their own prices. Go-to-market mixes enterprise sales (sponsors, CROs, biotech investors) with self-serve product-led registration for sites and doctors. The company is privately held, founder-controlled (President & Founder Jorge Toro), has 11–50 employees, and shows no disclosed external funding or institutional investors — implying the business has been bootstrapped against recurring subscription and partnership economics.

Name

Medinexo

Legal name

MEDINEXO USA, LLC

Website

https://medinexo.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Medinexo is a healthcare communications network connecting biotech and pharma sponsors with 1,800+ pre-qualified clinical trial sites across 35+ countries via ResearchNexo, TeamNexo, and PatientNexo platforms, monetizing through sponsor and site subscriptions plus a federated Real World Data marketplace.

Ownership category

akta.pro rank

Product category

Clinical Trial Site Network and Healthcare Technology Platform

NAICS

Medical and Diagnostic Laboratories (6215), Offices of Physicians (62111)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medication Analytics, Outcomes & Cost Optimization (HLACAKAL)

akta.pro secondary industry

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)

Keywords

• Clinical trial site network
• Federated real-world data
• Telemedicine platform
• Healthcare data marketplace
• Sponsor site recruitment

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Sponsor Prime Subscription: Monthly subscription at $485/month for unlimited access to site network and dashboards. Site recruiting service priced at $2,501 per site enrollment for one trial protocol. 90-day money-back guarantee if no site qualifies.
2. Site Prime Membership: Monthly subscription at $99/month for research sites to join network, get marketing exposure, certifications, and RWD monetization. Basic free tier available with limited features.
3. PatientNexo Transaction Fees: 10% transaction fee on doctor services (7-day chat, video-conference) with $1 minimum per transaction. Doctors receive payments via deposit or wire transfer.
4. ResearchNexo IP Data Marketplace: Institutions pay $99/month subscription to monetize clinical data access. Medinexo facilitates transactions between data providers and sponsors through federated computing platform. Institutions set their own prices per patient/cohort.
5. Data Asset Access Requests (DAAR): Sponsors create data requests with ultra-detailed filters broadcast to 1,800+ sites. Negotiate per-case pricing through interactive dashboard. Payment processing built into platform.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Medinexo operates a Healthcare Communications Network that connects biotech and pharmaceutical sponsors with 1,800+ pre-qualified clinical trial sites across 35+ countries through its ResearchNexo platform, while providing telemedicine (PatientNexo) and team management (TeamNexo) tools to healthcare providers. The company enables clinical trial site recruitment, real-world data access via a federated computing marketplace (ResearchNexo Interface Processor), and direct patient-provider HIPAA-compliant communications via WhatsApp and SMS. Revenue is generated through sponsor subscriptions, site memberships, transaction fees on telemedicine, and a data marketplace commission structure.

Product overview

Medinexo is a Healthcare Communications Network providing a platform-plus-modules architecture with three core products for healthcare providers (ResearchNexo© for clinical research sites, TeamNexo© for team management, and PatientNexo© for telemedicine/patient communication), subscription-based site membership programs (PRIME SITE with Free Basic and $99/month Prime tiers), sponsor services (Site Search, Real World Data via federated computing, and Site Recruiting at $2,501/site), and patient services (CRAACO for connecting patients to trials). The platform spans 1,800+ sites across 35+ countries and includes data monetization tools (ResearchNexo Interface Processor) and biotech investor advisory services.

Differentiator

Problem solved

Functional benefit

Brands

• ResearchNexo©: Proprietary service providing tools, training, and know-how to become a sustainable research site for clinical trials.
• TeamNexo©
• PatientNexo©
• Sponsor Prime
• ResearchNexo Interface Processor (RNX IP)

Products and services

• ResearchNexo Proprietary service providing healthcare providers with the tools, training, and know-how to become a sustainable clinical trial site. Once registered as ResearchNexo Ready Site, Medinexo markets the site to sponsors and CROs for funded clinical trial participation.
• TeamNexo Service for healthcare provider teams, from small practices to clinics and hospitals, providing patient portfolio management and team coordination including telemedicine visits, HIPAA-compliant virtual communications, and secure prescription delivery.
• PatientNexo Virtual care platform for healthcare professionals to communicate with patients, providing HIPAA-compliant telemedicine, secure prescription and test results delivery, patient surveys, and document handling. Patients interact via WhatsApp or SMS without installing an app, while providers operate from the PatientNexo portal.
• PRIME SITE (ResearchNexo PRIME for Sites) Paid membership program (Free Basic tier at $0 and Prime tier at $99/month with year subscription) that provides research sites with site readiness verification, ResearchNexo Rating, GDPR credential management, advanced certifications, direct access to sponsors, proactive marketing, and data monetization via the ResearchNexo Interface Processor.
• Sponsor Prime Site Search Platform for sponsors to search and recruit clinical trial sites across 1,800+ pre-qualified sites in 35+ countries, with 360° site dashboards, BlueCloud certifications, built-in e-learning, electronic credential management, and digital onboarding.
• Sponsor Prime Data (Real World Data) Federated Real World Data marketplace enabling sponsors to create ultra-segmented Data Asset Access Requests (DAARs) filtered by age, comorbidities, geography, and biomarkers across 1,800+ sites. Data is accessed via Federated Computing (SOC 2 Type 2 and ISO 27001 certified) so no identifiable data leaves the provider's server.
• Site Recruiting One-time recruiting and onboarding service for sponsors priced at $2,501 USD per site per trial protocol, including site identification, feasibility form completion, pre-study qualification, electronic credential management, e-learning system, and recorded virtual visit. Carries a 90-day money-back guarantee if no site is accepted.
• Biotech Investor Services Advisory services for biotech investors including clinical trial planning, feasibility assessment, budget assessment, execution preparation, and trial execution management to help reduce risk for investments in portfolio companies.
• CRAACO (Clinical Research as a Care Option) Program connecting patients with clinical trials as a care option. Medinexo members can connect their patients to innovative healthcare programs through the ResearchNexo program.

Quantifiable outcome

• Site recruitment time reduced from months to days
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature6 records

Partnerships

14 partnerships are on record, tiered major, strategic, minor and core.

• EtCuraemajorStrategic or Co-development Partner · 16 March 2026SMO and Scientific Services S.A.P.I. de C.V. partnered with Medinexo for LATAM RWE initiatives. EtCurae extends population reach through strategic partnerships with public health institutions, hospitals, research centers across Mexico and Latin America. Focus areas include chronic diseases, metabolic disorders, pediatrics.
• SURAmajorStrategic or Co-development Partner · 23 February 2026Servicios de Salud IPS Suramericana S.A.S. partnered with Medinexo for clinical research and healthcare innovation. Headquartered in Medellin, Colombia, SURA serves 5.3 million lives and is a leader in Latin American healthcare industry.
• INCT Urogen BrazilstrategicStrategic or Co-development Partner · 8 November 2025Strategic partnership strengthening international oncology research by connecting research sites in the INCT network, improving data quality, and fostering innovation across Latin America.
• CAIMEDmajorChannel Partner/ Reseller/ Distributor · 8 September 2025Clinical research organization with over 18 years of success joined Medinexo global network. Founded in 2007 in Bogotá, CAIMED has grown to be an international network with sites in Colombia, Mexico, Dominican Republic, and US.
• IDCBISminorChannel Partner/ Reseller/ Distributor · 28 April 2025Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud joined Medinexo global network. Bogotá-based institution with 15+ years in science, technology and innovation in health with emphasis on medical and biotechnological research.
• Hospital DIOMEDminorChannel Partner/ Reseller/ Distributor · 7 April 2025Hospital DIOMED joined ResearchNexo PRIME network. Mexican hospital with commitment to excellence in patient care and healthcare innovation, adding to growing community of leading research institutions.
• Passport HealthmajorChannel Partner/ Reseller/ Distributor · 12 March 2025Largest travel medicine provider in US joined Medinexo network with 300+ travel clinics. Brings access to millions of potential clinical trial participants across the United States.
• Home Medical Management (HMM)coreTechnology or Integration · 24 September 2024Medinexo Technology Partner recognized in Top 50 Healthcare Technology Companies of 2025 by The Healthcare Technology Report. HMM provides home medical management technology solutions.
• Access Health LouisianaminorChannel Partner/ Reseller/ Distributor · 30 May 2024Access Health Louisiana joined Medinexo network. Operates 53 community health centers and school-based health centers in 16 parishes in Southeast Louisiana, bringing diversity to clinical research industry.
• Rhino HealthcoreTechnology or Integration · 22 May 2024Global leader in federated computing partnered with Medinexo to expand data diversity in therapeutic development. Partnership enables Medinexo's federated computing technology for privacy-preserving data analysis across the network.
• CUBIO Innovation CenterstrategicStrategic or Co-development Partner · 1 February 2023Collaboration initiative in ResearchReadiness for life science innovation. Joint development of tools and services to support biotech companies and clinical research sites.
• Total Outcomes PartnersstrategicStrategic or Co-development Partner · 8 March 2022Partnership to develop Diversity Centers of Excellence in Clinical Trials. Medinexo had created network of 1,500+ physicians across globe serving diverse populations in multiple therapeutic areas with focus on telemedicine.
• BlueCloudcoreTechnology or IntegrationBlueCloud provides healthcare technology integration services. Medinexo website links to BlueCloud (healthcarepoint.com) as a partner, with joint offerings including BlueCloud Certifications (GDPR Wallet) for clinical trial site credentials and accreditations.
• Partners For PatientscoreStrategic or Co-development PartnerPhilanthropic organization focused on expanding healthcare access in Africa through Project CARE initiative. Medinexo collaborates on clinical research and healthcare innovation efforts in underserved regions.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva is a broad incumbent in clinical trial and life sciences technology (CTMS, eTMF, Vault), competing with Medinexo at the sponsor-facing layer but across a much larger enterprise software portfolio.
• IQVIA: IQVIA is the largest CRO with significant digital health and real-world evidence offerings, representing the incumbent that Medinexo's disintermediation value proposition is explicitly positioned against.

Direct peers

• Medable: Medable is a decentralized clinical trial platform that connects sponsors, sites, and patients — directly comparable to Medinexo's ResearchNexo and PatientNexo offerings, with a stronger focus on DCT technology.
• Antidote: Antidote (formerly TrialReach) operates a clinical trial patient recruitment and matching platform — comparable to Medinexo's site search and CRAACO patient-matching capabilities.
• Clario: Clario provides clinical trial technology and eCOA/decentralized trial solutions, with overlapping scope in clinical trial data capture and site enablement comparable to Medinexo's site network.
• THREAD: THREAD is a decentralized clinical trial and telehealth platform that combines virtual site operations with patient-facing telemedicine — closely paralleling Medinexo's combined site network + PatientNexo telehealth model.
• Reify Health: Reify Health (StudyTeam) is a direct competitor in clinical trial site performance and sponsor-to-site connection, addressing the same pain point of accelerating site identification, onboarding, and activation for pharma sponsors.
• Aetion: Aetion is a real-world evidence analytics platform serving pharma sponsors, directly comparable to Medinexo's RNX IP RWE/RWD marketplace but with a software-led (rather than federated-network) model.
• Science 37: Science 37 operates a decentralized clinical trial site network and patient recruitment platform, competing directly with Medinexo's sponsor-facing site search and recruitment services.

Emerging players

• ObvioHealth: ObvioHealth is an emerging decentralized clinical trial vendor with site-network and telehealth capabilities, offering partial overlap with Medinexo's ResearchNexo + PatientNexo combination at an earlier stage of scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Medinexo
• LinkedInlinkedin.com/company/medinexo
• Instagraminstagram.com/medinexocares
• Facebookfacebook.com/Medinexosupport

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medinexo